Bio-Rad Laboratories (FRA:BUWA) Inventories, Raw Materials & Components: €186 Mil (As of Mar. 2026)


FRA:BUWA Bio-Rad Laboratories Inc FRA:BUWA
72 GF Score
Price €256.60
GF Value €272.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bio-Rad Laboratories Inventories, Raw Materials & Components?

Bio-Rad Laboratories FRA:BUWA -0.23% 72 Inventories, Raw Materials & Components is €186 Mil as of Mar. 2026. GuruFocus rates FRA:BUWA with a GF Score™ of 72/100 and a GF Value™ of €272.77 (Fairly Valued). The stock has 5 warning signs investors should review.

Bio-Rad Laboratories's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €186 Mil.

Bio-Rad Laboratories's quarterly raw materials declined from Sep. 2025 (€191 Mil) to Dec. 2025 (€181 Mil) but then increased from Dec. 2025 (€181 Mil) to Mar. 2026 (€186 Mil).

Bio-Rad Laboratories's annual raw materials declined from Dec. 2023 (€212 Mil) to Dec. 2024 (€212 Mil) and declined from Dec. 2024 (€212 Mil) to Dec. 2025 (€181 Mil).

Bio-Rad Laboratories Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Bio-Rad Laboratories's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Rad Laboratories Inventories, Raw Materials & Components Chart

Bio-Rad Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.46 215.99 212.38 212.01 181.48

Bio-Rad Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.69 201.06 190.76 181.48 185.72
FRA:BUWA
72GF Score
Bio-Rad Laboratories Inc FRA:BUWA
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Rad Laboratories Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €186 Mil mean?
Bio-Rad Laboratories (FRA:BUWA) has a Inventories, Raw Materials & Components of €186 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Bio-Rad Laboratories and its competitors.
Is Bio-Rad Laboratories' Inventories, Raw Materials & Components too high?
Bio-Rad Laboratories' current Inventories, Raw Materials & Components is €186 Mil. Overall, Bio-Rad Laboratories has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Rad Laboratories' Inventories, Raw Materials & Components compare to GKOS and BRKR?
Bio-Rad Laboratories' Inventories, Raw Materials & Components of €186 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Bio-Rad Laboratories and its competitors. Bio-Rad Laboratories's current Inventories, Raw Materials & Components is €186 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Rad Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Bio-Rad Laboratories (FRA:BUWA) is currently considered Fairly Valued. The stock's GF Value™ is €272.77, compared to a current price of €256.60 — trading 5.9% below its estimated fair value. The current Inventories, Raw Materials & Components is €186 Mil. Bio-Rad Laboratories' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Bio-Rad Laboratories (FRA:BUWA), the current Inventories, Raw Materials & Components is €186 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Rad Laboratories (FRA:BUWA) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Rad Laboratories stock appears to be undervalued. The current stock price of €256.60 is trading 5.9% below its estimated GF Value™ of €272.77. GuruFocus considers Bio-Rad Laboratories to be Fairly Valued.

Key valuation signals for FRA:BUWA:

  • Inventories, Raw Materials & Components: €186 Mil
  • GF Value™: €272.77 vs. price of €256.60 (5.9% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the FRA:BUWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Rad Laboratories Business Description

Address 1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
72GF Score

Get the complete analysis for FRA:BUWA

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€256.60
Price
€272.77
GF Value